Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...
Morning Overview on MSN
New catheter aims to improve arrhythmia treatment as clinical trials begin
For the roughly 6 million Americans living with atrial fibrillation, catheter ablation has become an increasingly common ...
(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...
Columnist Kylene Henderson's husband, Donnie, had to pivot in many aspects of life due to PF, including changing his career.
Tectonic Therapeutic is reviving relaxin biology with TX45, targeting Group 2 Pulmonary Hypertension with HFpEF. Check out ...
The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...
Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...
University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results